Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 197

The DOI matches its Crossref record.

PROGRESSIVE MYOCLONUS EPILEPSY: A Clinical and Histopatliological Study

Koskiniemi, M., Donner, M., Majuri, H., Haltia, M., Norio, R.·2009·Acta Neurologica Scandinavica

Abstract

The clinical picture and the progression of the disease in 93 cases of progressive myoclonus epilepsy in Finland were analysed. The disease was familial in 25 out of 67 families. The incidence was calculated to be one in 27000 live-born children, i.e. three new cases each year. The early development and health of the patients was normaI. The first obvious symptom of the disease occurring at the age of 6 to 15 years was either myoclonus or grand mal seizures, the other following later. The characteristic clinical picture also included ataxia, intention tremor, dysarthria as well as emotional lability, but only a slight decrease in the intelligence level. Raised arterial pressure was seen in 14 per cent of cases. Symptoms from other organs were generally lacking. Resistance to infectious diseases seemed to be lower than normally. The thickness of the skull was increased but other disturbances of hone were not found. The pneumoencephalograms did not show any clear atrophy of the brain. The most essential feature of the disease was myoclonus which was provoked by light, touch and other stimuli and it was an important sign for the diagnosis. The increase of myoclonus finally made the patient unable to move unaided and to take care of himself and rendered him bedridden and helpless, most frequently at the age of 17 to 18 years. The average age at death was 24 years, about 14 years after the appearance of the first symptoms. In some patients the progress of the disease came to a halt after many years and these patients sometimes lived for up to 20–30 years after the beginning of the disease. A thorough neuropathological examination was made in one case and in five other cases some autopsy specimens from the brain were examined. Biopsy specimens from other tissues such as peripheral nerves, liver and muscle were examined in 26 cases. The most outstanding feature of the brain was loss of Purkinje cells. No Lafora bodies were found and no other signs of pathological accumulating material. Thus the Finnish cases of progressive myoclonus epilepsy do not belong to the Lafora body type of the disease. Clinically they differ from this type mainly on the basis of the fairly high intelligence level.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-0404.1974.tb02782.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Metadata

Authors
Koskiniemi, M., Donner, M., Majuri, H., Haltia, M., & Norio, R.
Venue
Acta Neurologica Scandinavica
Published
2009-01-29
Volume
50
Issue
3
Pages
307-332
ISSN
  • 0001-6314 (ISSN-L)
  • 1600-0404
OpenAlex
W2116325277
Cited by
197
References
0
FWCI
6.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PROGRESSIVE MYOCLONUS EPILEPSY: A Clinical and Histopatliological Study. https://app.cochat.ai/papers/10.1111/j.1600-0404.1974.tb02782.x
The paper
Koskiniemi, M., Donner, M., Majuri, H., Haltia, M., & Norio, R. (2009). PROGRESSIVE MYOCLONUS EPILEPSY: A Clinical and Histopatliological Study. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1974.tb02782.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.